U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614113) titled 'Atropine Alone vs Atropine Plus Bifocal Spectacles for Myopia Control in Children' on May 20.
Brief Summary: Background: Myopia (nearsightedness) is a growing global health concern, projected to affect 50% of the world population by 2050. Children with progressive myopia are at risk of serious ocular complications including myopic maculopathy, glaucoma, and retinal detachment. Low-dose atropine (0.05%) has shown efficacy in slowing myopia progression, and optical interventions such as bifocal spectacles may provide additional benefits by altering peripheral retinal defocus. Objective: This randomized controlled trial aims to compare ...